Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsAmeriHealth Step Therapy Coverage Update | OpenPay…
    Ask Trek AI about this page
    CurrentAmeriHealthPolicy N/A

    Step therapy Premium Formulary — Step therapy program (drug step therapy list)

    Customize your policy alerts

    Sign up for all AmeriHealth policy alerts

    Know when AmeriHealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medications placed on a step therapy program for AmeriHealth members and explains that members must try specified lower-step (step 1) drugs before higher-step (step 2) drugs will be covered; affects prescribing clinicians, pharmacists, and members under AmeriHealth benefit plans.

    Policy Summary
    PayerAmeriHealth
    PolicyStep therapy Premium Formulary — Step therapy program (drug step therapy list)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionEnsure pharmacy claims show prior trial of the required Step 1 medication before dispensing Step 2 agents; pharmacist may contact prescriber if prior step is not documented.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2026-07-01effective date for step therapy requirements
    Multipletherapeutic classes listed
    Step 1 before Step 2core program rule
    Subject to changelist variability

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Step Therapy Coverage Criteria

    Step therapy coverage condition

    Covered when the following step rule is met

    Step therapy requirement: Member has trial of required Step 1 medication(s) prior to Step 2 medicationprior trial documented on pharmacy claims or other acceptable documentation

    If prior trial not shown, pharmacist may contact prescriber; exceptions and prior authorization pathways may exist per plan

    Step therapy requirements may vary by benefit plan and are effective July 1, 2026. The listed step therapy medications are subject to change without notice. In addition to the step therapy rules, additional clinical programs — including quantity limits and prior authorization — may apply to drugs on this list and could affect prescription drug coverage.

    Provider Responsibilities and Workflow

    Step Therapy

    Follow the step therapy workflow before dispensing

    Members must try a step 1 medication first; if pharmacy claims show prior use of the required step 1 medication, the step 2 medication may be filled. If prior step use is not shown, the pharmacist may contact the prescriber to explain next steps.

    Prior Authorization

    Check for prior authorization and quantity limits

    Additional clinical programs may affect coverage for listed medications. Quantity limits and prior authorization may apply and could change coverage or processing.

    Documentation Required

    Ensure prior-step documentation is available

    Pharmacy claims history must document a prior trial of the designated step 1 medication for the step 2 medication to be filled without intervention; pharmacists may contact the prescriber if prior-step documentation is not present.

    Denial Risk

    Missing step 1 trial may result in denial or manual processing

    Claims for step 2 medications may be denied or not auto-processed unless pharmacy claims show prior use of the required step 1 medication; pharmacists may contact the prescriber if prior step is not documented.

    Policy Background

    Step therapy prioritizes use of lower-cost, clinically appropriate medications first. Members must try the designated Step 1 medication(s) before a Step 2 medication will be covered; if a member has tried and failed or cannot tolerate the Step 1 option, Step 2 coverage may be considered per plan rules. Pharmacy claims history or other acceptable documentation should demonstrate the prior trial of the required Step 1 medication to avoid processing delays or potential denials.

    Key Definitions

    Step therapy: Step 1 / Step 2
    Definition: Step 1Lower‑cost medication(s) that must be tried first before a Step 2 medication may be covered
    Definition: Step 2Higher‑cost medication(s) that require prior trial of the designated Step 1 option(s) for coverage
    WorkflowWhen a prescription is presented, the pharmacy system checks for step therapy; if pharmacy claims show recent trial of a Step 1 medication, the Step 2 may be filled; otherwise the pharmacist may contact the prescriber
    Documentation requiredPharmacy claims or other acceptable documentation must show prior trial of the required Step 1 medication to avoid pharmacist intervention
    Member actionMembers listed on the program are encouraged to discuss treatment and medication options with their doctor and may call the phone number on the member ID card for questions

    Initial (Step 1) Therapy

    Initial (Step 1) therapy — Step 1 medication examples

    Step 1 medication examples

    Step 1 requirement examples: Examples: For Bacterial Vaginosis Agents, any one of the following generics must be tried first: clindamycin 2% vaginal cream or metronidazole 0.75% vaginal gel; for Oral Tetracyclines, any one of the following generics must be tried first: doxycycline or minocycline; for selected cardiovascular and RAS agents, any one of the listed generics (e.g., benazepril, lisinopril, losartan, candesartan, etc.) must be tried first; for ADHD agents, any one of the listed generics (e.g., amphetamine–dextroamphetamine IR/ER, dexmethylphenidate IR/ER, methylphenidate IR/ER, lisdexamfetamine) must be tried first

    Documented trials of these generics are required prior to coverage of corresponding Step 2 brand products; see full drug list for additional classes and specific generic options

    Step Therapy Drug Pairings and Table

    Therapeutic class / conditionStep 1 (required trial)Step 2 (requires Step 1 trial)
    Step 1: Any one of the following generics: clindamycin 2% vaginal cream; metronidazole 0.75% vaginal gel. Step 2: VANDAZOLE.
    Step 2: SOLOSEC; brands for tetracyclines include AVIDOXY, MONDOXYNE NL, VIBRAMYCIN; other brand entries as listed.
    Step 2: SEYSARA; CETRAXAL.
    Step 2: ALTOPREV; EZALLOR; FLOLIPID; FENOGLIDE; FIBRICOR; LIPOFEN (per class-specific entries).
    Step 2: EDARBI; EDARBYCLOR (and other brand combinations listed).
    Step 2: Brands listed include APTENSIO XR; AZSTARYS; CONCERTA; DESOXYN; DEXEDRINE; JORNAY PM; METHYLIN; METHYLPHENIDATE ER; PROCENTRA; RELEXXII; VYVANSE; ONYDA XR (per document).
    Step 2: TIGLUTIK; TEGLUTIK; BRIVIACT; XCOPRI; MOTPOLY XR (and other brand agents listed).
    Step 2: Brands include APLENZIN; FETZIMA; DESVENLAFAXINE ER; DRIZALMA; PAXIL SUSPENSION; TRINTELLIX; VIIBRYD; CAPLYTA (per pairings in document).
    Step 2: Brands include EDLUAR; ZOMIG; ZOLMITRIPTAN NASAL SPRAY; GRALISE; gabapentin once‑daily formulations; SAVELLA; others as listed.
    Step 2: Brands include FINACEA GEL; ZILXI; ONEXTON; VTAMA; ZORYVE (cream/foam); SERNIVO; KLISYRI; OPZELURA; EUCRISA; ZORYVE CREAM 0.05%/0.15%; other named brand topicals.
    Step 2: Brands include KLISYRI; imiquimod cream 3.75%; CYCLOSET; RIOMET; LINZESS; PRUCALOPRIDE; SYMPROIC; MOTEGRITY; FIRST‑OMEPRAZOLE; FIRST‑PANTOPRAZOLE; LANSOPRAZOLE SUSPENSION; PRILOSEC PACKET; PROTONIX PACKET (as listed).
    Step 2: Brands include febuxostat (ULORIC); FERAHEME; ferumoxytol; INJECTAFER; FOSRENOL; IMVEXXY; OSPHENA; PREMARIN VAGINAL CREAM; XELPROS; EPIPEN; SYMBICORT; BREO/ADVAIR HFA; CARDURA XL; ENTADFI; GELNIQUE; OXYTROL; MYRBETRIQ; and other brand products cited in the document.

    Quantity Limits and Related Guidance

    Quantity limits and related programs
    Quantity limits referenceSee the Premium Quantity Limits document for quantity limits that may apply to the listed medications
    Additional clinical programsStep therapy medications may also be subject to other clinical programs, including prior authorization, which could affect coverage
    Effective dateStep therapy requirements effective July 1, 2026
    Plan variationStep therapy requirements may vary by benefit plan and the medication list is subject to change without notice
    Policy Summary
    PayerAmeriHealth
    PolicyStep therapy Premium Formulary — Step therapy program (drug step therapy list)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionEnsure pharmacy claims show prior trial of the required Step 1 medication before dispensing Step 2 agents; pharmacist may contact prescriber if prior step is not documented.
    SourceLink
    On This Page
    Step Therapy Coverage CriteriaProvider Responsibilities and WorkflowPolicy BackgroundKey DefinitionsInitial (Step 1) TherapyStep Therapy Drug Pairings and TableQuantity Limits and Related Guidance